Kowalska Irina, Straczkowski Marek, Szelachowska Małgorzata, Kinalska Ida, Prokop Jolanta, Bachórzewska-Gajewska Hanna, Stepien Agnieszka
Department of Endocrinology, Diabetology, and Internal Medicine, Medical Academy in Białystok, Poland.
Metabolism. 2002 Jun;51(6):733-6. doi: 10.1053/meta.2002.32802.
It is hypothesized that adhesion molecules could be an early predictor of coronary artery disease. Therefore we investigated the relationship between the concentrations of soluble forms of adhesion molecules and disturbances of glucose metabolism in 78 men referred for coronary angiography but with no previous history of diabetes. The group consisted of 78 men (mean age, 47.6 +/- 7.0 years; mean body mass index [BMI], 28.4 +/- 3.24 with the symptoms of angina pectoris and positive exercise test. All subjects were given a standard oral glucose tolerance test (OGTT) with glucose and insulin estimations. Fasting plasma concentrations of the soluble (s) forms of E-selectin, intercellular adhesion cell molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and HbA(1c) were also measured. According to the OGTT, 10.2% of the patients (n = 8) fulfilled the criteria for type 2 diabetes mellitus and 44.9% (n = 35) for impaired glucose tolerance (IGT). The highest concentrations of sE-selectin were observed in patients with type 2 diabetes mellitus and were significantly higher in comparison to the group with normal glucose tolerance and IGT. The concentration of sVCAM-1 increased with the progression of disturbances of glucose metabolism and remained the highest in type 2 diabetic patients. sICAM-1 concentration was not significantly different. sE-selectin concentration correlated significantly with fasting glucose (r = 0.23, P =.041), postload glucose (r = 0.39, P =.001), and postload insulin (r = 0.28, P =.023). sVCAM-1 was significantly related to the postload glucose concentration (r = 0.30, P =.009). A significant correlation between sICAM-1 concentration and postload insulin was also observed (r = 0.27, P =.025). This would suggest that hyperglycemia increases sE-selectin and sVCAM-1 in plasma, which reflects excessive formation of atherosclerotic plaques in patients with disturbances of glucose metabolism.
据推测,黏附分子可能是冠状动脉疾病的早期预测指标。因此,我们对78名因冠状动脉造影前来就诊但既往无糖尿病史的男性患者,研究了可溶性黏附分子浓度与糖代谢紊乱之间的关系。该组由78名男性组成(平均年龄47.6±7.0岁;平均体重指数[BMI]28.4±3.24),有胸痛症状且运动试验呈阳性。所有受试者均接受了标准口服葡萄糖耐量试验(OGTT)并测定了血糖和胰岛素水平。还测定了E-选择素、细胞间黏附分子-1(ICAM-1)、血管细胞黏附分子-1(VCAM-1)的可溶性(s)形式以及总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)和糖化血红蛋白(HbA1c)的空腹血浆浓度。根据OGTT结果,10.2%的患者(n = 8)符合2型糖尿病标准,44.9%(n = 35)符合糖耐量受损(IGT)标准。2型糖尿病患者中可溶性E-选择素浓度最高,与糖耐量正常组和IGT组相比显著更高。可溶性VCAM-1浓度随糖代谢紊乱程度加重而升高,在2型糖尿病患者中最高。可溶性ICAM-1浓度无显著差异。可溶性E-选择素浓度与空腹血糖(r = 0.23,P = 0.041)、负荷后血糖(r = 0.39,P = 0.001)和负荷后胰岛素(r = 0.28,P = 0.023)显著相关。可溶性VCAM-1与负荷后血糖浓度显著相关(r = 0.30,P = 0.009)。可溶性ICAM-1浓度与负荷后胰岛素之间也观察到显著相关性(r = 0.27,P = 0.025)。这表明高血糖会增加血浆中可溶性E-选择素和可溶性VCAM-1,这反映了糖代谢紊乱患者动脉粥样硬化斑块的过度形成。